Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy. [electronic resource]
Producer: 20210118Description: 769-779 p. digitalISSN:- 1569-8041
- DNA, Viral -- genetics
- Epstein-Barr Virus Infections -- pathology
- Herpesvirus 4, Human -- genetics
- Humans
- Nasopharyngeal Carcinoma -- therapy
- Nasopharyngeal Neoplasms -- radiotherapy
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Plasma
- Prognosis
- Prospective Studies
- Retrospective Studies
- Risk Assessment
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.